Evidence map›Paper›PMID 29954074›Full record

ArticleMolecules (Basel, Switzerland)2018

Hydrophilic Interaction Liquid Chromatography-Electrospray Ionization Mass Spectrometry for Therapeutic Drug Monitoring of Metformin and Rosuvastatin in Human Plasma.

Nikolaos Antonopoulos, Giorgos Machairas, George Migias, Ariadni Vonaparti, Vasiliki Brakoulia, Constantinos Pistos, Dimitra Gennimata, Irene Panderi

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Nikolaos AntonopoulosLaboratory of Pharmaceutical Analysis, School of Pharmacy, Division of Pharmaceutical Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis, Zografou, 15771 Athens, Greece. nikos_antono@windowslive.com.
Giorgos MachairasLaboratory of Pharmaceutical Analysis, School of Pharmacy, Division of Pharmaceutical Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis, Zografou, 15771 Athens, Greece. giorgosmachairas@yahoo.com.
George MigiasGeneral Hospital of Athens Alexandra, 80 Vas. Sofias Avenue, 11528 Athens, Greece. g.migias@gmail.com.
Ariadni VonapartiQatar Doping Analysis Laboratory, Sports City Road, Aspire Zone, P.O. Box 27775, Doha, Qatar. avonaparti@adlqatar.qa.
Vasiliki BrakouliaLaboratory of Pharmaceutical Analysis, School of Pharmacy, Division of Pharmaceutical Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis, Zografou, 15771 Athens, Greece. vasilikibrakoulia@gmail.com.
Constantinos PistosDepartment of Chemistry, West Chester University, West Chester, PA 19383, USA. cpistos@wcupa.edu.
Dimitra GennimataGeneral Hospital Korgialenio-Benakio National Red Cross, Erithrou Stavrou 1, 11526 Athens, Greece. dimigenn@gmail.com.
Irene PanderiLaboratory of Pharmaceutical Analysis, School of Pharmacy, Division of Pharmaceutical Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis, Zografou, 15771 Athens, Greece. irenepanderi@gmail.com.
National and Kapodistrian University of Athens · GRAlexandra Hospital · GRAnti-Doping Laboratory · QAHellenic Red Cross · GRWest Chester University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this work a hydrophilic interaction liquid chromatography/positive ion electrospray mass spectrometric assay (HILIC/ESI-MS) has been developed and fully validated for the quantitation of metformin and rosuvastatin in human plasma. Sample preparation involved the use of 100 μL of human plasma, following protein precipitation and filtration. Metformin, rosuvastatin and 4-[2-(propylamino) ethyl] indoline 2 one hydrochloride (internal standard) were separated by using an X-Bridge-HILIC BEH analytical column (150.0 × 2.1 mm i.d., particle size 3.5 μm) with isocratic elution. A mobile phase consisting of 12% (

Indexed as

Chromatography, LiquidHumansMetforminRosuvastatin CalciumSpectrometry, Mass, Electrospray IonizationMetforminRosuvastatin CalciumHILICLC-MSmetforminrosuvastatintherapeutic drug monitoring

Identifiers

PMID29954074
PMCPMC6100608
OpenAlexW2810890494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.